STEVEN LAMM: Open Payments
NPI 1992856702 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,042 in 25 payments from 5 companies in 2025. Trend: 2023 $639 · 2024 $740 · 2025 $2,042
Consulting: $1,395Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $1,572 |
| InspireMD Ltd | 2 | $303 |
| Alkermes, Inc. | 4 | $75 |
| Eisai Inc. | 3 | $64 |
| Lilly USA, LLC | 1 | $28 |
Products named: CGuard Prime Carotid Stent System, Ozempic, VIVITROL, Leqembi, Rybelsus, Wegovy, ZEPBOUND.
Industry payments across NY — which companies pay providers there.
